Targeting T regulatory cells in autoimmune diseases

Israel Medical Association Journal

Volumn 10, Issue 1, 2008, Pages 73-76

  Toubi, Elias ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Autoimmune diseases; Rheumatoid arthritis; Systemic lupus erythematosus; T regulatory cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CYTOSTATIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; L SELECTIN; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; STEROID; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; FORKHEAD TRANSCRIPTION FACTOR; IMMUNOLOGIC FACTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE COURSE; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; DOWN REGULATION; DRUG EFFECT; LYMPHOCYTE ACTIVATION; METABOLISM; REVIEW;

ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41149175222     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004;10:801-5.
2. + regulatory T cells in autoimmunity and allergy. Curr Opin Immunol 2002;14:771-8.
3. + regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 2005;4:491-6.
4. + T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J Autoimmun 2006;26:24-31.
5. Alvarado-Sanchez B, Hernandez-Castro B, Portales-Perez D, et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2006;27:110-18.
6. + T cells from the target organ of patients with RA. Eur J Immunol 2003;33:215-23.
7. + T cells through the production of IL-10. J Immunol 2001;166:3008-18.
8. + regulatory cells. Autoimmun Rev 2002;1:190-7.
9. +CD25 high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 2006;45:1210-17.
10. Behrens F, Himsel A, Rehart S, et al. Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis. Ann Rheum Dis 2007;66:1151-6.
11. + T cells in peripheral blood of patients with SLE. Scand J Immunol 2004;59:198-202.
12. + regulatory T-cell population and autoantibody levels in pediatric patients with systemic lupus erythematosus. Immunology 2006;117:280-6.
13. +CD25highFoxP3 regulatory T cells in patients with systemic lupus erythematosus. Adv Exp Med Biol 2007;601:113-19.
14. +CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis 2006;65:1512-17.
15. +CD25high T regulatory cell function in patients with active SLE. J Immunol 2007;178:2579-88.
16. Sfikakis PP, Souliotis VL, Fragiadaki KG, Moutsopoulos HM, Boletis JN, Theofilopoulos AN. Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin Immunol 2007;123:66-73.
17. +CD25high T-regulatory cells. Blood 2006;108:253-61.
18. +T cells in patients with active rheumatoid arthritis is reduced by infliximab. Ann N Y Acad Sci 2005;1051:506-14.
19. Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007;204:33-9.
20. Karagiannidis C, Akidis M, Holopainen P, et al. Glucocorticoids up regulate FoxP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004;114:1425-33.
21. Kessel A, Ammuri H, Peri R, et al. IVIg therapy affects T reg cells by increasing their suppressive function. J Immunol 2007;179:5571-5.
22. Lories RJ, Casteels-van Daele M, Ceuppens JL, van Gool SW. Polyclonal immunoglobulins for intravenous use induce IL-10 release in vivo and in vitro. Ann Rheum Dis 2004;63:747-8.